The U.S. Senate has approved a bill aimed at speeding up regulatory approval for pharmaceuticals and medical devices, as well as providing extra funding for medical research, the Precision Medicine Initiative, and the cancer “moonshot.”

Biotech stocks fell nearly 5 percent Dec. 7, after Time magazine published an interview with President-elect Donald Trump's interview with Time magazine, in which he vowed to take action to control drug prices.

If Republicans in Congress move forward with plans to repeal the Affordable Care Act (ACA) without a replacement ready, hospitals could lose hundreds of billions of dollars.

The antitrust trial on Aetna’s proposed $37 billion acquisition of Humana began Dec. 5, with the U.S. Department of Justice beginning to make its case that the merger would reduce competition and raise prices for patients and hospitals.

Major medical associations largely praised the choice of U.S. Rep. Tom Price, MD, R-Georgia, for HHS Secretary, but those endorsements didn't sit well with some doctors.